| Product Code: ETC9685876 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Glycopeptide Antibiotics Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Glycopeptide Antibiotics Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Glycopeptide Antibiotics Market - Industry Life Cycle |
3.4 Thailand Glycopeptide Antibiotics Market - Porter's Five Forces |
3.5 Thailand Glycopeptide Antibiotics Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Thailand Glycopeptide Antibiotics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Thailand Glycopeptide Antibiotics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Thailand Glycopeptide Antibiotics Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Thailand Glycopeptide Antibiotics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Glycopeptide Antibiotics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of antibiotic-resistant infections in Thailand |
4.2.2 Increasing awareness about the benefits of glycopeptide antibiotics |
4.2.3 Rise in healthcare expenditure and government initiatives to improve healthcare infrastructure in Thailand |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new antibiotics in Thailand |
4.3.2 Competition from alternative antibiotic therapies and treatments |
5 Thailand Glycopeptide Antibiotics Market Trends |
6 Thailand Glycopeptide Antibiotics Market, By Types |
6.1 Thailand Glycopeptide Antibiotics Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Vancomycin, 2021- 2031F |
6.1.4 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Dalbavancin, 2021- 2031F |
6.1.5 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Oritavancin, 2021- 2031F |
6.1.6 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Thailand Glycopeptide Antibiotics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Skin and Structure Infection, 2021- 2031F |
6.2.3 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Meningitis, 2021- 2031F |
6.2.4 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Clostridioides Difficile Infection, 2021- 2031F |
6.2.5 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Enterocolitis, 2021- 2031F |
6.2.6 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Glycopeptide Antibiotics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Thailand Glycopeptide Antibiotics Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Thailand Glycopeptide Antibiotics Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 Thailand Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Glycopeptide Antibiotics Market Import-Export Trade Statistics |
7.1 Thailand Glycopeptide Antibiotics Market Export to Major Countries |
7.2 Thailand Glycopeptide Antibiotics Market Imports from Major Countries |
8 Thailand Glycopeptide Antibiotics Market Key Performance Indicators |
8.1 Number of new antibiotic-resistant infection cases reported annually in Thailand |
8.2 Adoption rate of glycopeptide antibiotics in Thai hospitals and healthcare facilities |
8.3 Research and development investment in new glycopeptide antibiotic formulations in Thailand |
9 Thailand Glycopeptide Antibiotics Market - Opportunity Assessment |
9.1 Thailand Glycopeptide Antibiotics Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Thailand Glycopeptide Antibiotics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Thailand Glycopeptide Antibiotics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Thailand Glycopeptide Antibiotics Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Thailand Glycopeptide Antibiotics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Glycopeptide Antibiotics Market - Competitive Landscape |
10.1 Thailand Glycopeptide Antibiotics Market Revenue Share, By Companies, 2024 |
10.2 Thailand Glycopeptide Antibiotics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here